Medication info

Infosizigen 5/80mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Introbiopharma Co., Ltd.
Appearance
Dark yellow round film-coated tablet
Packaging
30 tablets/PTP (10 tablets/PTP * 3)
Approval status
Active

MFDS item code 201603878 · Approved 2016.06.24

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medication is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before administering this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy with either individual component, switching directly to this medication may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams monotherapy, or with 5/160 milligrams. For patients taking valsartan and amlodipine concomitantly, switching to this medication (a combination product containing the same amounts of each active ingredient) may be considered for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher), but this medication should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medication to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients 65 years of age and older: Use caution when increasing the dose.
Child dose
The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Introbiopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

It is used to effectively lower and control blood pressure in patients with essential hypertension where blood pressure is not sufficiently controlled with either amlodipine or valsartan monotherapy.

How to take

Adult dose

The recommended dose of this medication is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before administering this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy with either individual component, switching directly to this medication may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams monotherapy, or with 5/160 milligrams. For patients taking valsartan and amlodipine concomitantly, switching to this medication (a combination product containing the same amounts of each active ingredient) may be considered for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher), but this medication should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medication to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients 65 years of age and older: Use caution when increasing the dose.

Child dose

The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be used in individuals with allergies to the active ingredient or similar compounds, pregnant or breastfeeding women, and patients with severe renal or liver impairment. In patients with sodium or fluid depletion, low blood pressure may occur, so the condition should be thoroughly checked before administration, and appropriate measures should be taken if hypotension occurs. Patients with high potassium levels or those taking medications that can increase potassium levels should have their potassium levels monitored frequently. Caution must be taken when using in patients with renal artery stenosis or those who have recently received a kidney transplant due to the risk of worsening renal function. If signs of angioedema occur, use should be discontinued immediately, and re-administration is prohibited. Patients with heart failure or after myocardial infarction should be closely monitored for changes in renal function while taking this medication. This medication may cause dizziness or fatigue when driving or operating machinery, so caution is advised. While taking this medication, blood pressure, renal function, and electrolyte levels should be regularly tested to ensure there are no abnormalities. Overdose can result in hypotension and arrhythmias, requiring immediate medical treatment. Women who are pregnant or planning to become pregnant should avoid taking this medication, and breastfeeding women are also advised against its use. It is not recommended in children due to insufficient safety and effectiveness data. Elderly patients may use the same dosage as general adults, but caution is required based on their condition. This medication may interact with other antihypertensive drugs, potassium supplements, and certain anti-inflammatory drugs; hence, individuals should consult their doctor or pharmacist about any other medications they are taking.

Side effects

Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, hemoglobin decrease, hematocrit decrease, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, elevated serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, double vision, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory reduction, taste disorders, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, dysuria, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroirritability, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuroirritability, sensory reduction, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly closed container. The recommended storage temperature is between 1 to 30 degrees Celsius. This helps to maintain the efficacy of the drug for a longer time and ensures safe use.

Appearance and packaging

Appearance

Dark yellow round film-coated tablet

Package unit

30 tablets/PTP (10 tablets/PTP * 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.